UBS ASSET MANAGEMENT AMERICAS LLC - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 115 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q2 2023$170,2500.0%32,0620.0%0.00%
Q1 2023$170,250
-55.8%
32,062
-47.7%
0.00%
Q4 2022$385,353
-99.9%
61,362
+2.2%
0.00%
Q3 2022$633,675,000
+88.2%
60,064
-3.2%
0.00%
Q2 2022$336,758,000
+21.1%
62,018
+104.7%
0.00%
Q1 2022$278,154,00030,3000.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$6,189,0007.17%
72 Investment Holdings, LLC 474,067$4,352,0004.76%
Velan Capital Investment Management LP 210,695$1,934,0001.80%
PFM Health Sciences, LP 4,370,545$40,122,0001.50%
Monashee Investment Management LLC 470,000$4,315,0001.25%
Avidity Partners Management LP 2,819,067$25,879,0000.54%
Rokos Capital Management LLP 849,334$7,899,0000.37%
Green Alpha Advisors, LLC 49,674$456,0000.31%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 181,304$1,664,0000.25%
Tekla Capital Management LLC 699,377$6,420,0000.22%
View complete list of CARIBOU BIOSCIENCES INC shareholders